6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Oral Drug Delivery Systems Based on Ordered Mesoporous Silica Nanoparticles for Modulating the Release of Aprepitant

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Two different types of ordered mesoporous nanoparticles, namely MCM-41 and MCM-48, with similar pore sizes but different pore connectivity, were loaded with aprepitant via a passive diffusion method. The percentage of the loaded active agent, along with the encapsulation efficiency, was evaluated using High-performance Liquid Chromatography (HPLC) analysis complemented by Thermogravimetric Analysis (TGA). The determination of the pore properties of the mesoporous particles before and after the drug loading revealed the presence of confined aprepitant in the pore structure of the particles, while Powder X-ray Diffractometry(pXRD), Differential Scanning Calorimetry (DSC), and FTIR experiments indicated that the drug is in an amorphous state. The release profiles of the drug from the two different mesoporous materials were studied in various release media and revealed an aprepitant release up to 45% when sink conditions are applied. The cytocompatibility of the silica nanoparticles was assessed in Caco-2 cell monolayers, in the presence and absence of the active agent, suggesting that they can be used as carriers of aprepitant without presenting any toxicity in vitro.

          Related collections

          Most cited references48

          • Record: found
          • Abstract: found
          • Article: not found

          Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

          A tetrazolium salt has been used to develop a quantitative colorimetric assay for mammalian cell survival and proliferation. The assay detects living, but not dead cells and the signal generated is dependent on the degree of activation of the cells. This method can therefore be used to measure cytotoxicity, proliferation or activation. The results can be read on a multiwell scanning spectrophotometer (ELISA reader) and show a high degree of precision. No washing steps are used in the assay. The main advantages of the colorimetric assay are its rapidity and precision, and the lack of any radioisotope. We have used the assay to measure proliferative lymphokines, mitogen stimulations and complement-mediated lysis.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Controlled growth of monodisperse silica spheres in the micron size range

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              A New Property of MCM-41:  Drug Delivery System

                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                14 February 2021
                February 2021
                : 22
                : 4
                : 1896
                Affiliations
                [1 ]Laboratory of Pharmaceutical Technology, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; dorachristophedc@ 123456gmail.com (T.C.); dfatouro@ 123456pharm.auth.gr (D.G.F.)
                [2 ]National Centre for Scientific Research “Demokritos”, 15341 Athens, Greece; d.giasafaki@ 123456inn.demokritos.gr (D.G.); t.steriotis@ 123456inn.demokritos.gr (T.S.)
                [3 ]Foundation for Research and Technology Hellas, Institute of Chemical Engineering and High Temperature Chemical Processes, 26504 Patras, Greece; nbouro@ 123456iceht.forth.gr or
                [4 ]Department of Materials Science, University of Patras, 26504 Patras, Greece
                [5 ]Laboratory of Pharmacology, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; theodorn@ 123456pharm.auth.gr (N.F.T.); ivizir@ 123456pharm.auth.gr (I.S.V.)
                [6 ]Department of Life and Health Sciences, University of Nicosia, CY-1700 Nicosia, Cyprus
                Author notes
                Author information
                https://orcid.org/0000-0002-6812-1779
                https://orcid.org/0000-0002-3922-7515
                https://orcid.org/0000-0003-1459-9774
                https://orcid.org/0000-0003-4978-7513
                https://orcid.org/0000-0001-5236-1500
                Article
                ijms-22-01896
                10.3390/ijms22041896
                7917702
                33672949
                f719e92a-2158-45f4-97bc-8fe5b470e5a8
                © 2021 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 14 January 2021
                : 11 February 2021
                Categories
                Article

                Molecular biology
                mesoporous materials,poorly soluble drugs,aprepitant,oral delivery
                Molecular biology
                mesoporous materials, poorly soluble drugs, aprepitant, oral delivery

                Comments

                Comment on this article